China NT Pharma's (HKG:1011) CEO Zhang Bozhi stepped down to devote more time to his personal and other affairs effective July 3, according to a same-day Hong Kong bourse filing.
Shares of the healthcare marketing company were up over 1% in Monday afternoon trading.
The company named NG, Andy Ching Kit, as its new CEO effective the same day. NG joined the company in 2018 and has held various positions including international business manager and general manager.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.